Supported by stringent statistical thresholds (p < 0.05, q < 0.05), these results provide mechanistic insight into how COL1A2 may facilitate bladder cancer progression through modulation of cell–matrix interactions. The gene discussed is COL1A2; the disease is urinary bladder carcinoma.